Nocturnal Enuresis clinical trials

Explore recruiting nocturnal enuresis clinical trials.

Recruiting nocturnal enuresis studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Nocturnal Enuresis trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A pharmacokinetic study of desmopressin - Minirin vs Sandoz

Denmark

Therapeutic use (Phase IV) EU CTIS Study details

A randomized, double-blind, placebo-controlled study of daridorexant treatment in adolescents with enuresis: proof-of-concept.

Denmark

Therapeutic confirmatory (Phase III) EU CTIS Study details

Nocturnal Enuresis trials by city

Nocturnal Enuresis in Toronto Nocturnal Enuresis in Vancouver Nocturnal Enuresis in Montreal Nocturnal Enuresis in Calgary Nocturnal Enuresis in Edmonton Nocturnal Enuresis in Ottawa Nocturnal Enuresis in Winnipeg Nocturnal Enuresis in Quebec City Nocturnal Enuresis in Hamilton Nocturnal Enuresis in Kitchener Nocturnal Enuresis in London Nocturnal Enuresis in Halifax Nocturnal Enuresis in New York Nocturnal Enuresis in Los Angeles Nocturnal Enuresis in Chicago Nocturnal Enuresis in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease